Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of California, Los Angeles
With
National Heart, Lung, and Blood Institute (NHLBI)
Age
12–21
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
A diagnosis of sickle cell disease
Age 12-21 years old
Fluent in English (the intervention will be delivered in English)
Participant is cognitively able to provide informed signed consent or assent
Participant is cognitively able to follow instructions
You may not be if
Under 12 years of age or over 21 years of age
Not fluent in English
Pain medication prescription has changed or if they have been hospitalized for a vaso-occlusive episode within 30 days of study participation.
Diagnosis of a condition (e.g., neurological disorder affecting peripheral sensation, skin abnormality over the stimulus site, obstructive sleep apnea, diabetes, ischemic heart disease) or cognitive impairment that may affect data integrity or the ability to complete study procedures.
Clareo Health | Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
